A Closing Thought

Articles

Key tips and resources to help evade the common traps of market landscaping-today an increasingly high-stakes and comprehensive task during clinical development.    

How to Avoid Common Pitfalls of Market Landscaping

To support complex in-home clinical research and investigative sites, well-designed trials must produce the same high-quality data as traditional sites. 

Ensuring High-Quality Data in Complex, In-Home Clinical Trials

With more common cancers now increasingly broken down by specific genomic defects, the future of research for any cancer is entirely, and unequivocally, molecular.

Any Cancer Can Be a 'Rare Cancer'

Lori Goldberg is CEO, Silverlight Digital

Digital media is becoming a crucial vehicle for finding “Patient X” for rare disease drug trials. Three areas in particular where digital media is helping with the detective work are explored.  

Finding Patient X: The Role of Digital Media in Rare Disease Research

To vie for success in the market for dermatologic therapies, companies developing biologics must navigate a series of significant challenges, including patient compliance and safety.

Dermatology Biologics: Overcoming Challenges to Fulfill Therapeutic Potential

The ruling by the Pennsylvania Supreme Court requiring informed consent to be obtained by a medical doctor could set a precedent for future nationwide cases involving clinical research.

How Does Shinal v. Toms Affect Informed Consent in Pennsylvania Clinical Trials?

Rolf Ehrhardt, MD, PhD is CEO of MedCision.

Automation will be key to improving efficiency and mitigating risk during the complex process of cell therapy production and delivery.

The Success of Cell Therapies Will Depend on Automation

As industry headlines buzz with drug pricing uncertainty and M&A speculation, sponsors can boost productivity on the R&D front through more conscious management of outsourcing spend.

The Productivity Opportunity that Biopharma is Missing

As Applied Clinical Trials celebrates its 25th birthday, longtime contributing author and columnist Ken Getz looks at the four truisms that still drive clinical trial operations today and into the future. 

Four Axioms That Will Always Explain Successful Clinical Performance

The language in Europe's Regulation (EU) 536/2014 regarding ethical review of protocols is concerning.